Related Experiment Video
Updated: Jan 1, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
Published on: November 13, 2012
The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor
Elizabeth A Coe1, Jennifer Y Tan2, Michael Shapiro1
1Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.
Abstract:
The MITF and SOX10 transcription factors regulate the expression of genes important for melanoma proliferation, invasion and metastasis. Despite growing evidence of the contribution of long noncoding RNAs (lncRNAs) in cancer, including melanoma, their functions within MITF-SOX10 transcriptional programmes remain poorly investigated. Here we identify 245 candidate melanoma associated lncRNAs whose loci are co-occupied by MITF-SOX10 and that are enriched at active enhancer-like regions. Our work suggests that one of these, Disrupted In Renal Carcinoma 3 (DIRC3), may be a clinically important MITF-SOX10 regulated tumour suppressor. DIRC3 depletion in human melanoma cells leads to increased anchorage-independent growth, a hallmark of malignant transformation, whilst melanoma patients classified by low DIRC3 expression have decreased survival. DIRC3 is a nuclear lncRNA that activates expression of its neighbouring IGFBP5 tumour suppressor through modulating chromatin structure and suppressing SOX10 binding to putative regulatory elements within the DIRC3 locus. In turn, DIRC3 dependent regulation of IGFBP5 impacts the expression of genes involved in cancer associated processes and is needed for DIRC3 control of anchorage-independent growth. Our work indicates that lncRNA components of MITF-SOX10 networks are an important new class of melanoma regulators and candidate therapeutic targets that can act not only as downstream mediators of MITF-SOX10 function but as feedback regulators of MITF-SOX10 activity.
Insights
Long noncoding RNAs (lncRNAs) are newly identified regulators in melanoma. This study reveals lncRNAs within MITF-SOX10 networks, including DIRC3, a tumor suppressor influencing melanoma growth and patient survival.
Area of Science:
- Melanoma research
- Cancer epigenetics
- Noncoding RNA biology
Background:
- MITF and SOX10 transcription factors are key regulators of melanoma progression.
- The role of long noncoding RNAs (lncRNAs) in melanoma's MITF-SOX10 transcriptional programs is largely unknown.
Purpose of the Study:
- To investigate the function of lncRNAs within MITF-SOX10 transcriptional networks in melanoma.
- To identify novel melanoma-associated lncRNAs regulated by MITF-SOX10.
Main Methods:
- Identification of candidate melanoma-associated lncRNAs co-occupied by MITF-SOX10 at active enhancer-like regions.
- Functional analysis of the lncRNA Disrupted In Renal Carcinoma 3 (DIRC3) in human melanoma cells.
- Assessment of DIRC3 expression in melanoma patients and correlation with survival.
Main Results:
- 245 candidate melanoma-associated lncRNAs were identified, co-occupied by MITF-SOX10.
- DIRC3 functions as a tumor suppressor, with its depletion increasing anchorage-independent growth in melanoma cells.
- Low DIRC3 expression in melanoma patients correlates with decreased survival.
- DIRC3 activates neighboring IGFBP5 tumor suppressor expression by modulating chromatin and suppressing SOX10 binding.
- DIRC3-IGFBP5 regulation impacts cancer-associated gene expression and anchorage-independent growth.
Conclusions:
- lncRNAs are integral components of MITF-SOX10 networks in melanoma, acting as both downstream mediators and feedback regulators.
- DIRC3 is a novel MITF-SOX10-regulated tumor suppressor lncRNA with clinical significance in melanoma.
- These lncRNAs represent a new class of melanoma regulators and potential therapeutic targets.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Master Transcription Regulators
Non-LTR Retrotransposons

